CREATe-1
Kv1.3
INNLIFES interview - VRG Therapeutics is the most innovative proposal of MIT4LS 2023

INNLIFES, an Italian online life science journal has published an interview with Tamás Kitka, PhD, our Director of Innovation and Portfolio. It covers VRG-K1, lead molecule of Kv1.3 project and our two proprietary platforms, ISEP and CREATe.
Note: The original language of this interview is Italian and was translated to English using Google Translate.

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 6, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 6, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
AI
Team
July 29, 2024
By VRG Therapeutics
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
AI
Team
July 29, 2024
By VRG Therapeutics
VRG Therapeutics has been selected among the "Early Stage Startups to Watch" in the drug discovery space by Sifted!
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life